AR075149A1 - Una formulacion multivitaminica/mineral para combatir los efectos del estres ambiental, mejorar la inmunidad y mejorara la energia y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega dosis de suplemento nutricional. - Google Patents

Una formulacion multivitaminica/mineral para combatir los efectos del estres ambiental, mejorar la inmunidad y mejorara la energia y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega dosis de suplemento nutricional.

Info

Publication number
AR075149A1
AR075149A1 ARP100100142A ARP100100142A AR075149A1 AR 075149 A1 AR075149 A1 AR 075149A1 AR P100100142 A ARP100100142 A AR P100100142A AR P100100142 A ARP100100142 A AR P100100142A AR 075149 A1 AR075149 A1 AR 075149A1
Authority
AR
Argentina
Prior art keywords
vitamin
biotin
effective amount
effects
mineral
Prior art date
Application number
ARP100100142A
Other languages
English (en)
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of AR075149A1 publication Critical patent/AR075149A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S607/00—Surgery: light, thermal, and electrical application
    • Y10S607/90—Substance abuse therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se proporcionan un suplemento nutricional, y métodos de uso del mismo, que están disenados para ser más efectivos en optimizar la salud, mejorar la energía y apariencia, reducir los efectos del estrés ambiental y mejorar, ayudar y asistir a la inmunidad de una persona, incluida, sin limitacion, a la reduccion de casos, duracion y gravedad de las infecciones de resfrío. Reivindicacion 1: Un método para mejorar la energía en un sujeto humano que lo necesite que posee (a) administracion de un suplemento nutricional que comprende: (1) una cantidad efectiva de vitamina B1, una cantidad efectiva de vitamina B2, una cantidad efectiva de niacina, una cantidad efectiva de vitamina B6, una cantidad efectiva de biotina, y una cantidad efectiva de ácido pantoténico; y (2) en donde la relacion en peso de biotina respecto de la vitamina B1 es entre 1:20 y 1:25; en donde la relacion en peso de biotina respecto de la vitamina B2 es entre 1:25 y 1:30; en donde la relacion en peso de biotina respecto de la niacina es entre 1:310 y 1:330; en donde la relacion en peso de biotina respecto de la vitamina B6 es entre 1:30 y 1:35; en donde la relacion en peso de biotina respecto de ácido pantoténico es entre 1:110 y 1:130; y (b) en donde el sujeto humano tiene energía mejorada. Reivindicacion 19: El método de la reivindicacion 1, en donde el suplemento nutricional además comprende vitamina A, betacaroteno, vitamina B12, vitamina C, niacina, vitamina D3, vitamina E, vitamina K1, ácido folico, calcio, fosforo, cloruro, cromo, sulfato de cobre, yodo, hierro, magnesio, manganeso, molibdeno, potasio, selenio, zinc y luteína.
ARP100100142A 2009-01-23 2010-01-22 Una formulacion multivitaminica/mineral para combatir los efectos del estres ambiental, mejorar la inmunidad y mejorara la energia y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega dosis de suplemento nutricional. AR075149A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14668909P 2009-01-23 2009-01-23

Publications (1)

Publication Number Publication Date
AR075149A1 true AR075149A1 (es) 2011-03-09

Family

ID=41718206

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100100142A AR075149A1 (es) 2009-01-23 2010-01-22 Una formulacion multivitaminica/mineral para combatir los efectos del estres ambiental, mejorar la inmunidad y mejorara la energia y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega dosis de suplemento nutricional.

Country Status (19)

Country Link
US (1) US20110274791A1 (es)
EP (1) EP2389177A1 (es)
JP (2) JP5722797B2 (es)
KR (3) KR20110117685A (es)
CN (3) CN105815770A (es)
AR (1) AR075149A1 (es)
AU (1) AU2010206791B2 (es)
BR (1) BRPI1007037A2 (es)
CA (1) CA2746902C (es)
CO (1) CO6410288A2 (es)
IL (2) IL213793A (es)
MX (1) MX2011007743A (es)
MY (1) MY160706A (es)
NZ (3) NZ618593A (es)
RU (2) RU2484824C2 (es)
SG (2) SG172761A1 (es)
TW (1) TWI612905B (es)
WO (1) WO2010085530A1 (es)
ZA (1) ZA201104318B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2573999C2 (ru) * 2014-03-21 2016-01-27 Омнифарма Юроп Лимитед Диетическая добавка в форме таблетки, содержащая йод и селен
US11466052B2 (en) * 2016-04-11 2022-10-11 Vytrus Biotech, S.L. Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment
CN107252473A (zh) * 2017-06-16 2017-10-17 刘保凤 一种强身健体保健药酒及其制备方法
KR200491241Y1 (ko) 2018-07-06 2020-03-09 대흥물산 주식회사 휠이 부착된 미닫이형 방충망 장치
CN111838679A (zh) * 2020-07-23 2020-10-30 美国营养有限公司 一种新型高效营养膳食补充剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740373A (en) * 1986-05-27 1988-04-26 Usv Pharmaceutical Corporation Stabilization of multivitamin/trace elements formulations
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
US5932624A (en) * 1995-10-17 1999-08-03 Herbert; Victor D. Vitamin supplement composition
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
EP1036510B1 (en) * 1999-03-18 2004-01-07 Bristol-Myers Squibb Company Vitamin formulation for cardiovascular health
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US6299896B1 (en) * 2000-04-13 2001-10-09 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
US20040213857A1 (en) * 2003-04-17 2004-10-28 Boehringer Ingelheim International Gmbh Multi-vitamin and mineral supplement for pregnant women
CA2560595C (en) * 2004-03-29 2013-01-22 Wyeth Multi-vitamin and mineral nutritional supplements
US20060228431A1 (en) * 2005-04-07 2006-10-12 Eben David J Nutriceutical tea
CN1762380A (zh) * 2005-09-30 2006-04-26 烟台益生药业有限公司 一种纳米硒制品及其制备方法
US20070190209A1 (en) * 2006-02-10 2007-08-16 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
RU2335925C2 (ru) * 2006-04-12 2008-10-20 Антон Викторович Сергеев Биологически активный препарат и способ его получения
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
US20080317725A1 (en) * 2007-06-20 2008-12-25 Baum Seth J Compositions and methods of treating chronic kidney disease

Also Published As

Publication number Publication date
US20110274791A1 (en) 2011-11-10
SG172761A1 (en) 2011-08-29
TW201031343A (en) 2010-09-01
SG10201800064UA (en) 2018-02-27
TWI612905B (zh) 2018-02-01
CA2746902A1 (en) 2010-07-29
NZ618593A (en) 2015-05-29
CN105815770A (zh) 2016-08-03
JP5722797B2 (ja) 2015-05-27
IL240493A (en) 2017-02-28
JP2012515783A (ja) 2012-07-12
KR20110117685A (ko) 2011-10-27
EP2389177A1 (en) 2011-11-30
RU2665635C2 (ru) 2018-09-03
CN103622035A (zh) 2014-03-12
MY160706A (en) 2017-03-15
IL213793A (en) 2016-08-31
AU2010206791A1 (en) 2011-07-07
KR20150016333A (ko) 2015-02-11
IL240493A0 (en) 2015-09-24
MX2011007743A (es) 2011-09-06
CN102292082A (zh) 2011-12-21
AU2010206791B2 (en) 2014-09-18
RU2484824C2 (ru) 2013-06-20
BRPI1007037A2 (pt) 2020-08-11
KR20160130526A (ko) 2016-11-11
WO2010085530A1 (en) 2010-07-29
RU2011128131A (ru) 2013-02-27
NZ593502A (en) 2013-12-20
RU2013119341A (ru) 2014-11-10
JP2015007092A (ja) 2015-01-15
CA2746902C (en) 2017-10-03
CO6410288A2 (es) 2012-03-30
ZA201104318B (en) 2012-02-29
IL213793A0 (en) 2011-07-31
NZ705666A (en) 2016-06-24

Similar Documents

Publication Publication Date Title
AR095104A1 (es) Método para disminuir el dolor articular inducido por el ejercicio en mamíferos no artríticos
CL2009002198A1 (es) Suplemento dietetico en forma de un gel blando que comprende luteina, zeaxantina, vitaminas c, e, d, b1, b2, b3, b6 y b12, cobre, zinc, folato/acido folico, selenio, manganeso, epa, dha y agua, el cual se ingiere una vez al dia para proveer la cantidad de dosificacion diaria; y metodos para reducir la respuesta inflamatoria ocular.
AR075149A1 (es) Una formulacion multivitaminica/mineral para combatir los efectos del estres ambiental, mejorar la inmunidad y mejorara la energia y al mismo tiempo tratar las deficiencias de vitaminas y minerales sin los efectos negativos colaterales de una mega dosis de suplemento nutricional.
PE20171138A1 (es) Modulacion inmunitaria
NZ593506A (en) Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health
AR049929A1 (es) Metodos y composiciones para el tratamiento de afecciones oftalmicas con derivados de retinilo
AR064332A1 (es) Composicion suplementaria nutricional o dietetica que fortalece y promueve la salud retinal
GT200600280A (es) Composiciones y metodos para el tratamiento de sintomas relacionados con el ciclo
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
BR112015026077A2 (pt) barra de sabão e método de redução de bactérias gram positivas em pele humana
CL2016001428A1 (es) Uso de una composicion con ejercicios cognitivos util para la prevencion o el tratamiento de un desarrollo cognitivo retrasado en los niños.
CO6450623A2 (es) Parasiticidas sanguineos
JP2012515783A5 (es)
BR112016002578A2 (pt) composições e método para fabricar solução aquosa de aminoácidos
CO6602160A2 (es) Terapia de b12 oral
EA201691969A2 (ru) Напиток для функционального питания
RU2012112099A (ru) Способ фармакологической коррекции ишемии скелетной мышцы миноксидилом
PE20151883A1 (es) Solucion electrolitica oral que contiene lactoferrina y usos de la misma
Werner et al. Evaluation of Average Nutrient Intakes of Collegiate Athletes and ROTC Cadets and Midshipmen
CL2015001118A1 (es) Proceso para obtener biológicamente nanopartículas de selenio, útiles en la suplementación dietaria de personas que padecen deficiencia de selenio, el cual comprende el cultivo de pantoea agglomerans cepa rmg 2147 en selenito de sodio, lisis celular, purificación de las nanopartículas y encapsulación de las mismas.
CO6490121A1 (es) Proceso innovador que nos permite obtener un suplemento dietario activante celular
AR082000A1 (es) Suplemento dietario para favorecer la actividad reproductiva humana
UA86230U (ru) Способ формирования неоциста после операций на органах малого таза
MX2016001903A (es) Mini-particulas de selenio organico y su uso via oral para suplementar las deficiencias de selenio en animales.
Arezoo et al. Do the other nutrients except calcium and vitamin D prevent the incidence of osteoporosis?

Legal Events

Date Code Title Description
FB Suspension of granting procedure